/ EN
2026-06-13 00:00 United States Policy & Regulation Regulatory Approval Translated from EN

FDA Clears Neuroelectrics Enobio Dx EEG Systems

Summary The FDA cleared Neuroelectrics Barcelona's Enobio Dx line, in 8-, 20- and 32-channel models, on June 13, 2026, finding it substantially equivalent under submission number K261604 through the special 510(k) pathway. The agency classifies it as a Full-Montage Standard Electroencephalograph, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Neuroelectrics is known in neuromodulation and BCI research for noninvasive EEG acquisition and transcranial electrical stimulation hardware.
Why it matters Research-grade EEG hardware only reaches patients once a cleared clinical version exists, and this entry dates that version for a headset already familiar from neuromodulation and BCI labs.

BCIwiki (bciwiki.com) — Neuroelectrics Barcelona S.L.U. received an FDA 510(k) decision of Substantially Equivalent for Enobio Dx (Enobio Dx 8);Enobio Dx (Enobio Dx 20);Enobio Dx (Enobio Dx 32) on June 13, 2026, under submission number K261604. The submission followed the Special 510(k) clearance pathway.

FDA lists the product under the device classification name Full-Montage Standard Electroencephalograph. It is a Class 2 device under regulation number 882.1400, assigned to the Neurology advisory committee. Neuroelectrics is known in neuromodulation and BCI research for noninvasive EEG acquisition and transcranial electrical stimulation hardware; the cleared Enobio Dx line comes in 8, 20 and 32 channel configurations.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About